LDC-526

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLDC-526
Drug Alias NameCDK9 Inhibitor (Lead Discovery/University of Duisburg-Essen)LDC-526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsLeukemia, Prolymphocytic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLead Discovery Center GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversitat Duisburg EssenLead Discovery Center GmbH
Active IndicationsN/A
Inactive IndicationsLeukemia, Prolymphocytic

Other Information

ATC CodeN/A
Related LinksN/A